The pan-HDAC inhibitor vorinostat potentiates the activity of the proteasome inhibitor carfilzomib in human DLBCL cells in vitro and in vivo (Retraction of Vol 115, Pg 4478, 2010)

Dasmahapatra G.; Lembersky D.; Kramer L.; Fisher R. I; Friedberg J.; Dent P.; Grant S.

首页> 外文期刊>Blood: The Journal of the American Society of Hematology >The pan-HDAC inhibitor vorinostat potentiates the activity of the proteasome inhibitor carfilzomib in human DLBCL cells in vitro and in vivo (Retraction of Vol 115, Pg 4478, 2010)

【24h】

The pan-HDAC inhibitor vorinostat potentiates the activity of the proteasome inhibitor carfilzomib in human DLBCL cells in vitro and in vivo (Retraction of Vol 115, Pg 4478, 2010)

机译：Pan-HDAC抑制剂Vorinostat在体外和体内促进了人DLBCL细胞中蛋白酶体抑制剂Carfilzomib的活性（VIVO，第115 Vol 115，PG 4478,1010）

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Blood: The Journal of the American Society of Hematology》 |2019年第1期|共1页
作者
Dasmahapatra G.; Lembersky D.; Kramer L.; Fisher R. I; Friedberg J.; Dent P.; Grant S.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病;
关键词

相似文献

外文文献
中文文献
专利

1. The pan-HDAC inhibitor vorinostat potentiates the activity of the proteasome inhibitor carfilzomib in human DLBCL cells in vitro and in vivo (Retraction of Vol 115, Pg 4478, 2010) [J] . Dasmahapatra G., Lembersky D., Kramer L., Blood: The Journal of the American Society of Hematology . 2019,第1期

机译：Pan-HDAC抑制剂Vorinostat在体外和体内促进了人DLBCL细胞中蛋白酶体抑制剂Carfilzomib的活性（VIVO，第115 Vol 115，PG 4478,1010）
2. Obatoclax Interacts Synergistically with the Irreversible Proteasome Inhibitor Carfilzomib in GC- and ABC-DLBCL Cells In Vitro and In Vivo (Retraction of Vol 11, Pg 1122, 2012) [J] . Dasmahapatra Girija, Lembersky Dmitry, Son Minkyeong P., Molecular cancer therapeutics . 2019,第6期

机译：Obatoclax在体外和体内在GC-和ABC-DLBCL细胞中使用不可逆的蛋白酶体抑制剂Carfilzomib与不可逆的蛋白酶体抑制剂CarfiLzomib（缩回第11卷，PG 1122,2012）之间的相互作用。
3. In Vitro and In Vivo Interactions between the HDAC6 Inhibitor Ricolinostat (ACY1215) and the Irreversible Proteasome Inhibitor Carfilzomib in Non-Hodgkin Lymphoma Cells (Retraction of Vol 13, Pg 2886, 2014) [J] . Dasmahapatra Girija, Patel Hiral, Friedberg Johnathan, Molecular cancer therapeutics . 2019,第6期

机译：在非霍奇金淋巴瘤细胞中的HDAC6抑制剂里吡喹酮（ACY1215）与不可逆蛋白酶体抑制剂Carfilzomib（Vol 13，PG 2886,2014的收缩）之间的体外和体内相互作用
4. Induction of heat shock protein 70 (Hsp70) by proteasome inhibitor MG 132 protects articular chondrocytes from cellular death in vitro and in vivo [C] . Laurent Grossin, Stephanie Etienne, Nadege Gaborit, International Symposium on Mechanobiology of Cartilage and Chondrocyte . 2004

机译：通过蛋白酶体抑制剂Mg 132诱导热休克蛋白70（Hsp70），在体外和体内保护特性软骨细胞免受细胞死亡的影响
5. Characterizing Acquired Proteasome Inhibitor Resistance in Human Multiple Myeloma Cell Lines [D] . Chen, Yedan 2017

机译：表征人类多发性骨髓瘤细胞系中获得的蛋白酶体抑制剂抗性。
6. Dasmahapatra G Lembersky D Kramer L Fisher RI Friedberg J Dent P Grant S. The pan-HDAC inhibitor vorinostat potentiates the activity of the proteasome inhibitor carfilzomib in human DLBCL cells in vitro and in vivo. Blood. 2010;115(22):4478-4487. [O] . -1

机译：Dasmahapatra GLembersky DKramer LFisher RIFriedberg JDent PGrantS。pan-HDAC抑制剂伏立诺他在体内和体外增强人DLBCL细胞中蛋白酶体抑制剂carfilzomib的活性。血液。 2010; 115（22）：4478-4487。
7. The pan-HDAC inhibitor vorinostat potentiates the activity of the proteasome inhibitor carfilzomib in human DLBCL cells in vitro and in vivo [O] . Dasmahapatra, Girija, Lembersky, Dmitry, Kramer, Lora, 2010

机译：pan-HDAC抑制剂伏立诺他在体内和体外增强蛋白酶体抑制剂卡非佐米在人DLBCL细胞中的活性。

The pan-HDAC inhibitor vorinostat potentiates the activity of the proteasome inhibitor carfilzomib in human DLBCL cells in vitro and in vivo (Retraction of Vol 115, Pg 4478, 2010)

著录项

引文网络

相似文献

相关主题

期刊订阅